According to Entrada Therapeutics's latest financial reports the company's current earnings (TTM) are C$0.12 B. In 2023 the company made an earning of -C$4.29 M an increase over its 2022 earnings that were of -C$0.14 B.The earnings displayed on this page is the company's Pretax Income.